Estrella Immunopharma, Inc.
ESLA
$0.64
$0.00-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.01M | -13.25M | -13.06M | -13.50M | -12.08M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 961.70K | 753.40K | 657.20K | 970.00K | 750.50K |
| Change in Net Operating Assets | -332.50K | 4.48M | 10.62M | 10.03M | 7.33M |
| Cash from Operations | -9.38M | -8.02M | -1.79M | -2.50M | -3.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.05M | 10.40M | 2.40M | 2.48M | 1.43M |
| Repurchase of Common Stock | 0.00 | 0.00 | -29.50K | -93.50K | -244.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -836.40K | -876.40K | -117.50K | -52.70K | -40.00K |
| Cash from Financing | 8.21M | 9.52M | 2.25M | 2.33M | 1.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.17M | 1.51M | 467.40K | -170.90K | -2.85M |